Rates of retention of persons with a mental health disorder in outpatient smoking cessation and reduction trials, and associated factors: protocol for a systematic review and meta-analysis.
Smoking
attrition
intervention
mental disorder
mental illness
methodology
retention
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
04 09 2019
04 09 2019
Historique:
entrez:
7
9
2019
pubmed:
7
9
2019
medline:
2
10
2020
Statut:
epublish
Résumé
Smoking among persons with a mental health disorder is associated with inequitable health, social and economic burden. Randomised controlled trials (RCTs) are considered the gold standard design for the assessment of healthcare intervention efficacy/effectiveness. However, many RCTs of smoking interventions for persons with a mental health disorder lack rigour due to low participant retention. No systematic review has pooled retention rates in randomised trials of smoking interventions for persons with a mental health disorder or explored associated factors. The aims of the systematic review will therefore be to: (1) summarise overall rates of participant retention in smoking cessation and reduction trials involving persons with a mental health disorder (including for experimental and control groups separately) and (2) determine if retention rates vary according to participant, environmental, researcher and study factors. PsycINFO, EMBASE, MEDLINE, CENTRAL and The Cochrane Tobacco Addiction Review Group Specialised Register will be searched for reports of RCTs of outpatient smoking cessation or reduction interventions for adults with a mental health disorder. The search terms will include MeSH terms and free text words, and there will be no language or date restrictions. All databases will be searched from inception to present. Data will be analysed using the Mantel-Haenszel fixed-effect model, and where substantial heterogeneity (I This study does not require ethical approval. The findings of this review will be disseminated via publication in a peer-reviewed open access medical journal and presentations at international scientific meetings.
Identifiants
pubmed: 31488491
pii: bmjopen-2019-030646
doi: 10.1136/bmjopen-2019-030646
pmc: PMC6731776
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e030646Subventions
Organisme : Cancer Research UK
ID : C56067/A21330
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Control Clin Trials. 1986 Sep;7(3):177-88
pubmed: 3802833
Annu Rev Public Health. 2010;31:297-314 1p following 314
pubmed: 20001818
Cochrane Database Syst Rev. 2013 Aug 21;(8):CD006102
pubmed: 23963776
Trials. 2014 Jan 23;15:32
pubmed: 24456928
BMC Public Health. 2009 Aug 07;9:285
pubmed: 19664203
Prev Chronic Dis. 2006 Apr;3(2):A42
pubmed: 16539783
Nicotine Tob Res. 2015 Mar;17(3):356-60
pubmed: 25180078
Evid Based Spine Care J. 2011 Feb;2(1):7-10
pubmed: 22956930
Cochrane Database Syst Rev. 2016 Mar 24;3:CD008286
pubmed: 27009521
J Clin Epidemiol. 2010 Aug;63(8):e1-37
pubmed: 20346624
PLoS One. 2018 Aug 29;13(8):e0203127
pubmed: 30157250
Trials. 2016 Oct 27;17(1):524
pubmed: 27788686
Syst Rev. 2018 Feb 20;7(1):30
pubmed: 29458415
Lancet. 2001 Apr 14;357(9263):1191-4
pubmed: 11323066
Cochrane Database Syst Rev. 2013 Feb 28;(2):CD007253
pubmed: 23450574
Nicotine Tob Res. 2017 Jan;19(1):24-31
pubmed: 27980040
Cochrane Database Syst Rev. 2016 Nov 23;11:CD010274
pubmed: 27878808
Arch Dis Child. 2008 Jun;93(6):458-61
pubmed: 18495909
Neuropsychiatr Dis Treat. 2016 Jun 10;12:1341-9
pubmed: 27354804
Trials. 2018 Feb 23;19(1):139
pubmed: 29475444
BMC Med Res Methodol. 2018 Dec 27;18(1):177
pubmed: 30587149
Psychol Health. 2015 Jan;30(1):122-34
pubmed: 25109224
JAMA. 2000 Nov 22-29;284(20):2606-10
pubmed: 11086367
BMC Public Health. 2011 Apr 19;11:249
pubmed: 21504610
Lancet. 2012 Dec 15;380(9859):2224-60
pubmed: 23245609
Arch Public Health. 2014 Nov 10;72(1):39
pubmed: 25810908
Psychol Addict Behav. 2000 Jun;14(2):134-42
pubmed: 10860112
MMWR Morb Mortal Wkly Rep. 2015 Nov 13;64(44):1233-40
pubmed: 26562061
Ann Behav Med. 2005 Apr;29 Suppl:55-65
pubmed: 15921490
Am J Health Promot. 2014 Mar-Apr;28(4):268-74
pubmed: 23875989
Arch Gen Psychiatry. 2004 Nov;61(11):1107-15
pubmed: 15520358
Lancet. 2002 Mar 2;359(9308):781-5
pubmed: 11888606
Aust N Z J Psychiatry. 2011 Apr;45(4):325-31
pubmed: 21142851
Syst Rev. 2015 Jan 01;4:1
pubmed: 25554246
CMAJ. 2008 Oct 7;179(8):751-3
pubmed: 18838445
Can J Nurs Res. 2004 Sep;36(3):82-98
pubmed: 15551664
Cochrane Database Syst Rev. 2013 Dec 03;(12):MR000032
pubmed: 24297482
Br J Psychiatry. 2001 Nov;179:432-7
pubmed: 11689401
BMC Med Res Methodol. 2014 Mar 25;14:42
pubmed: 24669751
Can J Nurs Res. 2015 Dec;47(4):21-40
pubmed: 29509476
Schizophr Res. 2005 Jul 15;76(2-3):135-57
pubmed: 15949648
BMJ. 2006 Apr 22;332(7547):969-71
pubmed: 16627519
Lancet. 2013 Mar 30;381(9872):1071
pubmed: 23541368
Health Res Policy Syst. 2015 Mar 12;13:8
pubmed: 25971302
BMJ Open. 2014 Feb 04;4(2):e003821
pubmed: 24496696
Am J Public Health. 2014 Aug;104(8):1557-65
pubmed: 23948001
Am J Psychiatry. 2013 Dec;170(12):1385-7
pubmed: 24306334
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120